MLR-ANN and RTO approach to μ-opioid receptor-binding affinity. Pooling data from different sources

Chemical Biology and Drug Design

Volumn 71, Issue 3, 2008, Pages 260-270

  Ramírez Galicia, Guillermo ^a,d   Garduño Juárez, Ramón ^a   Deeb, Omar ^b   Hemmateenejad, Bahram ^c  

^a INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^b AL QUDS UNIVERSITY   (Palestine)

^c SHIRAZ UNIVERSITY   (Iran)

^d UNIVERSIDAD DEL PAPALOAPAN   (Mexico)

Author keywords

receptor binding affinity; Artificial Neuron Network; Cheminformatics; Multiple Linear Regression; Quantitative structure activity relationship; Structure based drug design

Indexed keywords

MORPHINAN DERIVATIVE; MU OPIATE RECEPTOR; NIH 10945; NIH 11001; NIH 11011; NIH 11027; NIH 11028; NIH 11031; NIH 11037; NIH 11041; NIH 11044; NIH 11045; NIH 11050; NIH 11052; NIH 11053; NIH 11054; NIH 11055; NIH 11057; NIH 11058; NIH 11059; NIH 11060; NIH 11061; NIH 11062; NIH 11063; NIH 11065; NIH 11066; NIH 11067; NIH 11068; NIH 11072; NIH 11073; NIH 11074; NIH 11075; NIH 11076; NIH 11077; NIH 11081; NIH 11082; NIH 11088; NIH 11093; NIH 11095; NIH 11096; NIH 11097; NIH 11098; NIH 11100; NIH 11101; NIH 11109; NIH 11112; NIH 11113; NIH 11114; NIH 11116; NIH 11117; NIH 11118; NIH 11119; NIH 11120; NIH 11121; NIH 11127; NIH 11128; NIH 11130; NIH 11131; NIH 11132; NIH 11133; NIH 11134; NIH 11135; NIH 11136; NIH 11137; NIH 11139; NIH 11140; NIH 11144; NIH 11146; NIH 11149; NIH 11150; NIH 11151; NIH 11152; NIH 11153; NIH 11154; NIH 11164; NIH 11165; NIH 11166; NIH 11167; NIH 11168; NIH 11176; NIH 11177; NIH 11178; NIH 11179; NIH 11180; NIH 11181; NIH 11182; NIH 11183; NIH 11185; NIH 11186; NIH 11187; NIH 11188; NIH 11189; NIH 11190; NIH 11191; NIH 11192; NIH 11194; NIH 11195; NIH 11196; NIH 11197; NIH 11209; NIH 11210; NIH 11212; NIH 11213; NIH 11214; NIH 11231; NIH 11232; NIH 11233; NIH 11234; NIH 11248; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; DRUG RECEPTOR BINDING; MOLECULE; MULTIPLE LINEAR REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

MODELS, THEORETICAL; MORPHINANS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, OPIOID, MU;

EID: 38849174906     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00626.x     Document Type: Article

References (41)

1. Pert C.B., Snyder S.H. (1973) Opiate receptor: demonstration in nervous tissue. Science 179 : 1011 1014.
2. Law P.Y., Wong Y.H., Loh H.H. (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40 : 389 430.
3. Dhawan B.N., Cesselin F., Raghubir R., Reiseni T., Brandley P.B., Portoghese P.S., Hamon M. (1996) International Union of Pharmacology: XII. Classification of opioid receptors. Pharmacol Rev 48 : 567 592.
4. Abdelhamid E.E., Sultana M., Portoghese P.S., Takemori A.E. (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258 : 299 303.
5. Schiller P.W., Fundytus M.E., Merovitz L., Weltrowska G., Nguyen T.M., Lemieux C., Chung N.N., Coderre T.J. (1999) The opioid mu agonist/delta antagonist DIPP-NH(2) [Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. J Med Chem 42 : 3520 3526.
6. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., von Zastrow M. (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23 : 737 746.
7. Williams J.T., Christie M.J., Manzoni O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81 : 299 343.
8. Coop A., MacKerell A.D. Jr. (2002) The future of opioid analgesics. Am J Pharm Educ 66 : 153 156.
9. Hansch C., Leo A. (1995) Exploring QSAR: fundamental and application in chemistry and biology, Chapter 6. In : Heller S.R., editor. QSAR of Nonspecific Toxicity. Washington, DC : American Chemical Society p. 161 222.
10. Krogsgaard-Larsen P., Liljefors T., Madsen U., editors (2002) Textbook of Drug Design and Discovery. New York, USA : Taylor and Francis CRC Press.
11. Todeschini R., Consonni V. (2000) Handbook of Molecular Descriptors. Weinheim, Germany : Wiley-VCH.
12. Karelson M. (2000) Molecular Descriptors in QSAR/QSPR. New York, USA : Wiley-Interscience.
13. Peng Y., Keenan S.M., Zhang Q., Kholodovych V., Welsh W.J. (2005) 3D.QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies. J Med Chem 48 : 1620 1629.
14. Rong S.B., Zhu Y.C., Jiang H.L., Wang Q.M., Zhao S.R., Chen K.X., Ji R.Y. (1997) Interaction models of 3.methylfentanyl derivatives with μ opioid receptors. Acta Pharmacol Sin 18 : 128 132.
15. Commeta-Morini C., Maguire P.A., Loew G.H. (1992) Molecular determinants of μ receptor recognition for the fentanyl class of compound. Mol Pharmacol 41 : 185 196.
16. Xu L., Zhang W.J. (2001) Comparison of different methods for variable selection. Anal Chim Acta 446 : 475 481.
17. Schbeider G., Wrede P. (1998) Artificial neural networks for computer-based molecular design. Prog Biophys Mol Biol 70 : 175 222.
18. Coop A. (2005) Biological evaluation of opioid, stimulants, and depressants: I. An overview of the studies performed by the Drug Evaluation Committee of the college on problems of drug dependence (2004). In : Dewey W.L., editor. Problems of Drug Dependence 2004, vol. 185. Washington, DC : National Institute on Drug Abuse Research Monograph Series pp. 105 130.
19. Coop A. (2006) Biological evaluation of opioid, stimulants, and depressants: II. An overview of the studies performed by the Drug Evaluation Committee of the college on problems of drug dependence (2005). In : Dewey W.L., editor. Problems of Drug Dependence 2005, vol. 186. Washington, DC : National Institute on Drug Abuse Research Monograph Series p. 145 162.
20. TM.
21. Dewar M.J.S., Zeoblish E.G., Healy E.F., Stewart J.J. (1985) Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 107 : 3902 3909.
22. Baker J. (1993) An algorithm for the location of transition states. J Comput Chem 7 : 385 395.
23. Yamashita S., Furubayashi T., Kataoka M., Sakane T., Sezaki H., Tokuda H. (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10 : 195 204.
24. Todeschini R., Consonni V., Pavan M. (2002) Dragon Software Version 2.1-2002. Pisani 13, Milano, Italy : Dragon Software and references therein.
25. Guha R., Jurs P.C. (2005) Determining the validity of a QSAR model - a classification approach. J Chem Inf Model 45 : 65 73.
26. Topliss J.G., Costello R.J. (1972) Chance correlation in structure-activity studies using multiple regression analysis. J Med Chem 15 : 1066 1068.
27. Topliss J.G., Edwards R.P. (1979) Chance factors in studies of quantitative structure-activity relationships. J Med Chem 22 : 1238 1244.
28. Fernández M., Caballero J. (2007) QSAR models for predicting the activity of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A using quantum chemical properties. J Mod Model 13 : 465 476.
29. Hoffman R., Minkin V.I., Carpenter B.K. (1997) Ockham's razor and chemistry. HYLE Int J Phil Chem 3 : 3 28.
30. Walker C.A., Owasoyo J.O. (1974) The influence of serotonin, GABA, and DL-dopaon the circadian rhythm in the toxicity of picrotoxin, pentylenetetrazol and phenobarbital in mice. Int J Chronobiol 2 : 125 130.
31. 2! J Mol Graph Model 20 : 269 276.
32. Akaike H. (1974) A new look at the statistical model identification. IEEE Trans Automat Contr AC-19 : 716 723.
33. Kubinyi H. (1994) Variable selection in QSAR studies: 2. A highly efficient combination of systematic search and evolution. QSAR 13 : 393 401.
34. Anderson M.J., Legendre P. (1999) An empirical comparison of permutation methods for tests of partial regression coefficients in a linear model. J Stat Comput Simul 62 : 271 303.
35. Consonni V., Todeschini R., Pavan M. (2002) Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors: 1. Theory of the novel 3D molecular descriptors. J Chem Inf Comput Sci 42 : 682 692.
36. Portoghese P.S., Sultana M., Takemori A.E. (1990) Design of peptidomimetic delta opioid receptor antagonist using the message-address concept. J Med Chem 33 : 1714 1720.
37. Schuur J.H., Selzer P., Gasteiger J. (1996) The coding of the three dimensional structure of molecules by molecular transforms and its application to structure - spectra correlations and studies of biological activity. J Chem Inf Comput Sci 36 : 334 344.
38. Moran P.A.P. (1950) Notes on continuous stochastic processes. Biometrika 37 : 17 23.
39. Bauknecht H., Zell A., Bayer A.H., Levi P., Wagener M., Sadowski J., Gasteiger J. (1996) Locating biologically active compounds in medium-sized heterogeneous datasets by topological autocorrelation vectors: dopamine and benzodiazepine agonists. J Chem Inf Comput Sci 36 : 1205 1213.
40. Fries D.S. (1995) Opioid analgesics. In : Foye W.O., Lemke T.L., Williams D.A., editors. Principles of Medicinal Chemistry. Philadelphia, PA : Williams & Wilkins p. 453 479.
41. Ramírez-Galicia G., Garduño-Juárez R., Hemmateenjad B., Deeb O., Deciga-Campos M., Moctezuma-Eugenio J.C. (2007) QSAR study on the antinociceptive activity of some morphinans. Chem Biol Drug Des 70 : 53 64.